Integrated Diagnosis and Treatment of CKD on Outcomes

Launched by CAPITAL MEDICAL UNIVERSITY · Feb 12, 2022

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how well integrated diagnosis and treatment strategies can help patients with Chronic Kidney Disease (CKD). The goal is to follow 1,000 patients over time to see how effectively we can manage CKD and its related issues, such as high blood pressure, high blood sugar, and anemia, according to established guidelines. By closely monitoring these patients, the researchers hope to gather important information that can improve the care and outcomes for individuals with CKD.

To be eligible for this study, participants must be at least 18 years old and willing to provide informed consent. They should also be at risk of developing CKD. However, those under 18 or over 100 years old, or those who may not be able to follow study procedures, cannot participate. Patients in the study can expect regular check-ups, guidance on managing their condition, and support for a healthier lifestyle, all with the aim of enhancing their overall health and well-being.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • ≥18 years old;
• • Voluntarily signed informed consent;
• • Patients who are estimated to develop CKD.
• Exclusion Criteria:
• • Age \< 18 or ≥100 years;
• • Unable to comply with the procedures stipulated in this study;
• • Estimated follow-up time ≤6 months.